✦ LIBER ✦

ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease

✍ Scribed by Böger, Rainer H.; Zoccali, Carmine

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Asymmetric dimethylarginine (ADMA) as a

✍ Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 240 KB

PM320 Multiorgan versus single organ ath

✍ Wolff Gowdak, Luis Henrique; de Paula, Flavio J.; Cesar, Luiz Antonio M.; Bortol 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 122 KB

Factors associated with cardiovascular e

✍ J. Dierkes; U. Domroese; H.P. Bosselmann; K.H. Neumann; C. Luley 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Chronic kidney disease and risk of morta

✍ Gentile, Giorgio; Trillini, Matias 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 588 KB

Statins and cardiovascular risk reductio

✍ Usman Baber; Robert D. Toto; James A. de Lemos 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Laser Doppler flowmetry detection of end

✍ Kruger, A; Stewart, J; Sahityani, R; O'Riordan, E; Thompson, C; Adler, S; Garric 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 295 KB